Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Reyvow (lasmiditan) and Maxalt (rizatriptan) are both used to treat migraines, but they have some key differences. Reyvow (lasmiditan) is a serotonin agonist, while Maxalt (rizatriptan) is a triptan. Reyvow (lasmiditan) is only available as a brand-name medication, making it more expensive, whereas Maxalt (rizatriptan) is available in a lower-cost generic form. Reyvow (lasmiditan) is a controlled substance due to its potential for abuse, but Maxalt (rizatriptan) is not. Reyvow (lasmiditan) can cause significant dizziness and sleepiness, requiring you to avoid driving for at least 8 hours after taking it. Maxalt (rizatriptan) can also cause drowsiness but typically works faster, within 30 minutes. Additionally, Maxalt (rizatriptan) can be used by children ages 6 and older, while Reyvow (lasmiditan) is only approved for adults.
Reyvow (lasmiditan)
Rizatriptan (Maxalt)
Reyvow (lasmiditan)
Rizatriptan (Maxalt)
Summary of Reyvow vs. Maxalt
Summary for Serotonin agonist
Prescription only
Reyvow, the brand name for lasmiditan, is a serotonin agonist. It's used to treat migraine with or without aura in adults. It comes as a tablet that's taken by mouth when you have a migraine. Many people feel pain relief within 2 hours. Common side effects include dizziness, sleepiness, and a "pins-and-needles" feeling. Reyvow (lasmiditan) is a controlled substance because of the risk of misuse. Currently, Reyvow (lasmiditan) is a brand-name medication only; there's no generic yet.
Summary for Triptan
Prescription only
Rizatriptan (Maxalt) is used to treat migraines with or without aura in people ages 6 years and older. Rizatriptan (Maxalt) is available as a lower-cost generic tablet and an orally disintegrating tablet (ODT) that's placed on the tongue. Common side effects include dizziness, headache, and sleepiness. It can interact with antidepressants and other similar migraine medications.